RxDoctor Payments Data

Oscar Ochoa, MD

Plastic and Reconstructive Surgery · San Antonio, TXNPI 1871778928

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Coopersurgical, Inc. at 54.1% of the total. Reporting peaked in 2020 at $1,800 and has fallen 74.1% since, to $466 in 2025.

$4,162in general payments, 2019–2025

Across 28 payments — averaging $148.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopersurgical, Inc.$2K
  • AbbVie$762
  • TELA Bio, Inc.$249
  • Innovation Technologies Inc$196
  • Mentor Worldwide LLC$173
  • Motiva USA, LLC$149
  • plus $383 from 6 others
$30,493in research payments, 2019–2025

Across 20 payments — averaging $1524.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Axogen$30K

What the payments were for

  • Consulting fees$2,25054%
  • Food & beverage$1,86945%
  • Education$431%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,162 in reported general payments places this provider in the 60th percentile of 378 plastic and reconstructive surgery providers in Texas.

See all plastic and reconstructive surgery providers in Texas

Medicare billing

Part B allowed, 2024
$68,202
Medicare patients
28
Services billed
161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →